Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Low-density lipoprotein receptor-related protein 12 (LRP12) is a transmembrane receptor belonging to the low-density lipoprotein receptor family. It is implicated in the internalization of lipophilic molecules and/or signal transduction. LRP12 is differentially expressed in many cancer cells and may act as a tumor suppressor. Pathogenic expansion of CGG repeats in the LRP12 gene is associated with amyotrophic lateral sclerosis 28 (ALS28) and oculopharyngodistal myopathy 1. LRP12 participates in cellular pathways related to visual phototransduction and olfactory signaling[1][4][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Low-density lipoprotein receptor-related protein 12 (LRP12).